Oncostatin M‐Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin‐Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor

Mesenchymal stem cells (MSCs) are widely considered for treatment of pulmonary fibrosis based on the anti‐inflammatory, antifibrotic, antiapoptotic, and regenerative properties of the cells. Recently, elevated levels of oncostatin M (OSM) have been reported in the bronchoalveolar lavage fluid of a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Ying‐Wei, Theng, Si‐Min, Huang, Tsung‐Teng, Choo, Kong‐Bung, Chen, Chuan‐Mu, Kuo, Han‐Pin, Chong, Kowit‐Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442768/
https://www.ncbi.nlm.nih.gov/pubmed/28297588
http://dx.doi.org/10.5966/sctm.2016-0054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442768/
https://www.ncbi.nlm.nih.gov/pubmed/28297588
http://dx.doi.org/10.5966/sctm.2016-0054

Ejemplares similares